NCT05929443

Brief Summary

The goal of this feasibility study is to evaluate the feasibility of a complex intervention towards benzodiazepines and Z-drugs deprescribing in older adults living in the Belgian nursing home setting. The main questions it aims to answer are:

  • Is the intervention we developped feasible
  • To what extent will the intervention be implemented in nursing homes
  • To what extent is the design of the recruitment and data collection process feasible and acceptable for all participants Participants will benefit from a complex intervention implemented at the level of the nursing home, encompassing process and goals setting, healthcare providers education, environmental adaptations, audit and feedback on benzodiazepines use, use of educational leaflet with residents and relatives, and multidisciplinary work. Researchers will compare this intervention to usual care, to see if the intervention is feasible, and to gather first data on intervention effectiveness in benzodiazepines deprescriping.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

June 22, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 3, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

6 months

First QC Date

May 23, 2023

Last Update Submit

June 26, 2023

Conditions

Keywords

BenzodiazepinesDeprescribingLong-term careOlder adults

Outcome Measures

Primary Outcomes (5)

  • Nursing homes' adherence to the intervention

    has the intervention been implemented as intended, e.g. global number of implemented intervention components

    Assessed at 6 months

  • Healthcare providers responsiveness to the intervention

    has far did they respond to the intervention, and how far have them been engaged by the intervention, e.g level of attendance to education session for healthcare providers

    Assessed at 6 months

  • nursing home residents' responsiveness to the intervention

    has far did they respond to the intervention, and how far have them been engaged by the intervention

    Assessed at 6 months

  • Feasibility of the recruitment process

    The feasibility of the recruitment will be assessed through the ratio between included residents and residents contacted for participation.

    At 6 months

  • Feasibility of the data collection process

    Data collection process will be assessed through the quality of collected data (rate of missing data)

    At 6 months

Secondary Outcomes (7)

  • Contextual factors at the level of of the nursing home

    Baseline

  • Contextual factors at the level of the nursing home resident

    Baseline

  • Intervention mechanisms of impact

    At baseline

  • Intervention mechanisms of impact

    At 3 months

  • Intervention mechanisms of impact

    At 6 months

  • +2 more secondary outcomes

Study Arms (2)

END-IT intervention for nursing homes

EXPERIMENTAL

This complex intervention, implemented at the level of the nursing home, encompasses process and goals setting, education for healthcare providers, environmental adaptations, audit and feedback on benzodiazepine use, use of an educational leaflet for residents and relatives, and multidisciplinary work.

Other: END-IT intervention for nursing homes

Control

NO INTERVENTION

Usual care. Nursing homes allocated to this study arm will access intervention material at the end of the study.

Interventions

Complex intervention, as described in the arm/group descriptions

END-IT intervention for nursing homes

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • years old and older
  • Taking at least one benzodiazepine or Z-drug for 4 weeks or more

You may not qualify if:

  • Unability to communicate in French
  • Palliative care
  • Ongoing benzodiazepine withdrawal
  • Ongoing alcohol withdrawal
  • Severe anxiety
  • Severe depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLouvain

Woluwe-Saint-Lambert, 1200, Belgium

RECRUITING

Related Publications (1)

  • Evrard P, Chevallereau T, Aikpitanyi J, Petein C, Tubeuf S, Henrard S, Spinewine A. Feasibility of a theory-based intervention towards benzodiazepine deprescribing in Belgian nursing homes: protocol of the END-IT NH cluster-randomised controlled trial. BMJ Open. 2024 Oct 22;14(10):e085435. doi: 10.1136/bmjopen-2024-085435.

MeSH Terms

Interventions

Nursing Homes

Intervention Hierarchy (Ancestors)

Residential FacilitiesHealth FacilitiesHealth Care Facilities Workforce and Services

Study Officials

  • Anne Spinewine, PhD

    UCLouvain / Louvain Drug Research Institute / Clinical pharmacy research group

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Perrine Evrard, MPharm

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2023

First Posted

July 3, 2023

Study Start

June 22, 2023

Primary Completion

January 1, 2024

Study Completion

June 1, 2024

Last Updated

July 3, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Only publishable project data relating to the main analysis and research output will be shared on a data repository after an embargo period of two years after June 2024. All relevant documentation necessary to facilitate data re-use will be shared along with the datasets.

Locations